Insud Pharma
Nihal Hamdalla has a diverse work experience in the pharmaceutical industry. Nihal started their career in 2005 as a Medical Representative at Novartis. Nihal then worked at Bayer Pharmaceuticals, where they served as the Regulatory Manager-Gulf and later as a Product Specialist. Since 2016, Nihal has been with Insud Pharma, initially as the Regulatory, Quality, PV Director for the Middle East region and later as the Director of Supply, Regulatory, Quality, PV for the MEA (Middle East and Africa) region. Nihal has been responsible for setting regulatory strategies, ensuring fast access to new products, and maintaining the life cycle of current products while complying with internal and external regulations. Nihal is also credited as a key contributor in setting policies and procedures for a start-up business.
Nihal Hamdalla has completed the Corporate Development Program in Business Management at IESE Business School. Nihal also holds a Bachelor of Pharmacy (B.Pharm.) from the Faculty of Pharmacy at Cairo University. Nihal'searlier education includes attending Narmer Language School.
This person is not in any offices
Insud Pharma
5 followers
INSUD PHARMA operates across the entire pharmaceutical value chain, delivering specialized expertise and experience in scientific research, development, manufacturing, sales and marketing of a wide range of value-adding active pharmaceutical ingredients (APIs), finished dosage forms (FDFs) and branded pharmaceuticals, for human and animal health. While the main offices are located in Madrid, Lugano, Buenos Aires, INSUD PHARMA is acting worldwide, creating a broad and balanced manufacturing and commercial network across Europe, America, Asia and Africa, to address global opportunities and customers` needs in all major pharmaceutical markets. INSUD PHARMA's activity is organized in three synergistic business areas: Industrial (Chemo), Branded (Exeltis) and Biotech (mAbxience), with over 7,300 professionals in more than 50 countries, 18 state-of-the-art facilities, 15 specialized R&D centers, 12 commercial offices and more than 35 pharmaceutical affiliates, serving 1,150 customers in 96 countries around the world. INSUD PHARMA believes in innovation and sustainable development. Our commitment is to improve people`s health and quality of life, providing access to quality medicines at affordable prices, and to continuously expand our efforts and R&D investment to develop new and better therapies.